This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Amaxa Ag. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Tamara Turbanski
Introduction
Tamara Turbanski is a notable inventor based in Wiehl, Germany. She has made significant contributions to the field of biotechnology, particularly in the area of cell transfection. Her innovative work has led to the development of a unique method for transfecting cells, which has implications for gene therapy.
Latest Patents
Tamara Turbanski holds a patent for her invention titled "Modular Transfection Systems." This invention relates to a method for the transfection of cells using at least one protein capable of forming nucleoprotein filaments. The process involves modifying the protein with functional components that influence the transfection steps. The nucleic acid to be transfected is loaded with the modified protein, forming a filament-like complex that is then added to the target cells. This invention also includes a transfection agent consisting of nucleoprotein filaments, which can be used in pharmaceutical preparations for gene therapy.
Career Highlights
Throughout her career, Tamara has worked with prominent companies in the biotechnology sector, including Amaxa AG and Lonza Cologne GmbH. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking advancements in gene therapy.
Collaborations
Tamara has collaborated with esteemed colleagues such as Hanns-Martin Schmidt and Ludger Altrogge. These partnerships have further enhanced her research and development efforts in the field of biotechnology.
Conclusion
Tamara Turbanski's innovative work in cell transfection and gene therapy exemplifies her dedication to advancing biotechnology. Her contributions have the potential to significantly impact the treatment of genetic disorders in humans and animals.